virus
common
caus
acut
pharyng
children
adolesc
respiratori
virus
eg
influenza
viru
parainfluenza
viru
rhinoviru
coronaviru
adenoviru
respiratori
syncyti
viru
enterovirus
includ
coxsackieviru
echoviru
herp
simplex
viru
hsv
epsteinbarr
viru
ebv
frequent
caus
pharyng
ebv
pharyng
often
accompani
clinic
find
infecti
mononucleosi
eg
gener
lymphadenopathi
splenomegali
exud
indistinguish
ga
pharyng
hsv
pharyng
often
associ
stomat
children
tend
affect
entir
oral
mucosa
includ
gingiv
buccal
mucosa
tongu
enterovir
pharyng
isol
find
herpangina
part
spectrum
handfootandmouth
diseas
typic
appear
system
infect
virus
eg
cytomegaloviru
rubella
viru
measl
viru
also
includ
pharyng
ga
common
bacteri
caus
acut
pharyng
account
case
children
caus
bacteria
includ
group
c
g
streptococci
gc
gg
arcanobacterium
haemolyticum
rare
caus
adolesc
neisseria
gonorrhoea
caus
acut
pharyng
sexual
activ
adolesc
bacteria
francisella
tularensi
yersinia
enterocolitica
corynebacterium
diphtheria
well
mix
infect
anaerob
bacteria
eg
vincent
angina
rare
caus
chlamydophila
pneumonia
mycoplasma
pneumonia
implic
rare
particularli
adult
although
bacteria
staphylococcu
aureu
haemophilu
influenza
streptococcu
pneumonia
frequent
isol
throat
cultur
children
adolesc
acut
pharyng
etiolog
role
establish
fusobacterium
necrophorum
typic
etiolog
agent
lemierr
syndrom
also
may
caus
uncompl
pharyng
noninfecti
case
recurr
prolong
pharyng
sore
throat
includ
period
fever
aden
pharyng
aphthou
ulcer
pfapa
syndrom
gastroesophag
reflux
andor
laryngopharyng
reflux
allerg
rhiniti
case
acut
pharyng
occur
colder
month
year
respiratori
virus
preval
spread
among
famili
member
home
promin
featur
epidemiolog
agent
children
major
reservoir
ga
pharyng
primarili
diseas
children
year
age
temper
climat
preval
highest
winter
earli
spring
enterovir
pharyng
typic
occur
summer
earli
fall
gonococc
pharyng
occur
sexual
activ
adolesc
young
adult
usual
rout
infect
orogenit
sexual
contact
sexual
abus
must
consid
strongli
n
gonorrhoea
isol
pharynx
prepubert
child
widespread
immun
diphtheria
toxoid
made
diphtheria
rare
diseas
us
case
report
annual
recent
year
gc
gg
express
mani
toxin
ga
includ
streptolysin
gc
pharyng
clinic
featur
similar
ga
caus
elev
serum
antistreptolysino
aso
antibodi
gc
rel
common
caus
acut
pharyng
among
colleg
student
adult
seek
urgent
care
outbreak
gc
pharyng
relat
consumpt
contamin
food
product
eg
unpasteur
cow
milk
report
famili
school
although
also
sever
welldocu
foodborn
outbreak
gg
pharyng
etiolog
role
gg
acut
endem
pharyng
remain
unclear
communitywid
outbreak
pharyng
children
describ
gg
isol
consecut
children
acut
pharyng
seen
privat
pediatr
offic
result
dna
fingerprint
suggest
isol
belong
gg
clone
role
gc
gg
acut
pharyng
may
underestim
laboratori
may
use
bacitracin
suscept
identifi
ga
mani
gc
gg
bacitracinresist
addit
rapid
antigen
detect
test
radt
recogn
ga
cell
wall
carbohydr
nonreact
gc
gg
presenc
certain
clinic
epidemiolog
find
suggest
ga
caus
episod
acut
pharyng
box
patient
ga
pharyng
commonli
present
sore
throat
usual
sudden
onset
sever
pain
swallow
fever
headach
nausea
vomit
abdomin
pain
also
present
examin
typic
reveal
tonsillopharyng
erythema
without
exud
tender
enlarg
anterior
refer
avail
onlin
wwwexpertconsultcom
day
resolv
spontan
outbreak
pharyngoconjunctiv
fever
associ
transmiss
swim
pool
widespread
epidem
sporad
case
also
occur
enterovirus
coxsackieviru
echoviru
enterovirus
associ
erythemat
pharyng
tonsillar
exud
cervic
lymphadenopathi
unusu
fever
promin
resolut
usual
occur
within
day
herpangina
specif
syndrom
caus
coxsackievirus
b
echovirus
character
fever
pain
discret
greywhit
papulovesicularulc
lesion
erythemat
base
posterior
oropharynx
figur
handfootandmouth
diseas
character
pain
vesicl
ulcer
throughout
oropharynx
associ
vesicl
palm
sole
sometim
trunk
extrem
enterovir
lesion
usual
resolv
within
day
primari
oral
hsv
infect
usual
occur
young
children
typic
produc
acut
gingivostomat
associ
ulcer
vesicular
lesion
throughout
anterior
mouth
includ
lip
spare
posterior
pharynx
hsv
gingivostomat
last
week
often
associ
high
fever
pain
intens
poor
oral
intak
lead
dehydr
adolesc
adult
hsv
also
caus
mild
pharyng
may
may
associ
typic
vesicular
ulcer
lesion
ebv
pharyng
infecti
mononucleosi
sever
clinic
find
ident
ga
pharyng
figur
howev
gener
lymphadenopathi
hepatosplenomegali
also
present
posterior
cervic
lymphadenopathi
prestern
periorbit
edema
distinct
present
fever
pharyng
typic
last
week
wherea
lymphadenopathi
hepatosplenomegali
resolv
week
laboratori
find
includ
presenc
atyp
lymphocytosi
figur
heterophil
antibodi
viremia
pcr
specif
antibodi
ebv
antigen
amoxicillin
given
intens
maculopapular
rash
expect
figur
haemolyticum
pharyng
resembl
ga
pharyng
includ
presenc
scarlatiniform
rash
rare
haemolyticum
produc
membran
pharyng
confus
diphtheria
pharyng
diphtheria
character
greyish
brown
pseudomembran
limit
one
tonsil
extend
wide
involv
nare
uvula
soft
palat
pharynx
larynx
tracheobronchi
tree
involv
tracheobronchi
tree
lead
lifethreaten
respiratori
obstruct
cervic
lymph
node
find
includ
beefi
red
swollen
uvula
petechia
palat
scarlatiniform
rash
find
specif
ga
mani
patient
ga
pharyng
exhibit
sign
symptom
milder
classic
case
ill
patient
bona
fide
ga
infect
ie
rise
aso
antibodi
wherea
other
mere
colon
intercurr
viral
infect
ga
pharyng
infant
uncommon
difficult
differenti
viral
infect
nasopharyng
purul
nasal
discharg
excori
nare
frequent
accompani
pharyng
scarlet
fever
associ
characterist
rash
caus
pyrogen
exotoxin
erythrogen
toxin
produc
ga
occur
individu
lack
prior
antitoxin
antibodi
although
less
common
less
sever
past
incid
scarlet
fever
cyclic
depend
preval
toxinproduc
strain
ga
immun
statu
popul
mode
transmiss
age
distribut
epidemiolog
featur
otherwis
similar
ga
pharyng
rash
scarlet
fever
appear
within
hour
onset
sign
symptom
first
sign
rash
often
begin
around
neck
spread
trunk
extrem
diffus
fine
papular
sandpaperlik
erythemat
erupt
produc
bright
red
discolor
skin
blanch
pressur
involv
often
intens
along
creas
antecubit
area
axilla
groin
petechia
along
creas
occur
pastia
line
face
usual
spare
although
cheek
erythemat
pallor
around
mouth
figur
day
rash
begin
fade
follow
fine
desquam
first
face
progress
downward
occasion
sheetlik
desquam
occur
around
fingernail
periungu
palm
sole
pharyng
find
ga
pharyng
addit
tongu
usual
coat
papilla
swollen
desquam
redden
papilla
promin
give
tongu
strawberri
appear
presenc
certain
clinic
find
eg
conjunct
cough
hoars
coryza
anterior
stomat
discret
ulcer
lesion
viral
exanthema
myalgia
diarrhea
suggest
viru
rather
ga
caus
episod
acut
pharyng
see
adenoviru
pharyng
typic
associ
fever
erythema
pharynx
enlarg
tonsil
exud
enlarg
cervic
lymph
node
adenovir
pharyng
associ
conjunct
ill
refer
pharyngoconjunctiv
fever
pharyng
persist
day
conjunct
softtissu
edema
promin
cervic
subment
lymphadenopathi
caus
bullneck
appear
fusobacterium
necrophorum
may
common
caus
nonstreptococc
pharyng
occur
mani
adolesc
young
adult
pharyng
f
necrophorum
appear
caus
typic
sign
bacteri
pharyng
high
fever
odynophagia
lymphadenopathi
exud
tonsil
caus
concomit
bacteremia
frequenc
progress
tonsil
lemierr
syndrom
unknown
distinguish
ga
viral
pharyng
key
manag
us
score
system
incorpor
clinic
epidemiolog
featur
attempt
predict
probabl
ill
caus
ga
clinic
score
system
help
identifi
patient
low
risk
ga
infect
throat
cultur
radt
usual
unnecessari
howev
systemat
review
articl
individu
symptom
sign
pharyng
assess
articl
data
predict
rule
symptom
sign
individu
combin
predict
rule
could
use
diagnos
ga
pharyng
probabl
ad
complex
diagnosi
abil
distinguish
ga
pharyng
bacteri
pathogen
gc
similar
clinic
manifest
therefor
recent
guidelin
infecti
diseas
societi
america
idsa
well
guidelin
american
academi
pediatr
aap
american
heart
associ
aha
indic
microbiolog
confirm
either
throat
cultur
radt
requir
diagnosi
ga
pharyng
decis
perform
microbiolog
test
child
adolesc
acut
pharyng
base
clinic
epidemiolog
characterist
ill
see
histori
close
contact
document
case
ga
pharyng
high
preval
ga
commun
also
help
select
use
diagnost
studi
ga
increas
proport
posit
test
result
also
percentag
patient
posit
test
truli
infect
rather
mere
ga
carrier
adult
infrequ
infect
ga
rare
develop
rheumat
fever
practic
guidelin
center
diseas
control
prevent
cdc
american
academi
famili
physician
aafp
american
colleg
physiciansamerican
societi
intern
medicin
acpasim
recommend
use
clinic
algorithm
without
microbiolog
confirm
accept
approach
diagnosi
ga
pharyng
adult
although
goal
algorithmbas
strategi
reduc
inappropri
use
antibiot
adult
pharyng
approach
could
result
administr
antimicrobi
treatment
unaccept
larg
number
adult
nonga
pharyng
accord
studi
intend
assess
impact
six
differ
guidelin
identif
treatment
ga
pharyng
children
adult
guidelin
recommend
select
use
radt
andor
throat
cultur
treatment
base
posit
test
result
significantli
reduc
inappropri
use
antibiot
adult
contrast
empir
strategi
propos
cdcaafpacpasim
guidelin
result
administr
unnecessari
antibiot
unaccept
larg
number
adult
therefor
diagnosi
adult
symptomcomplex
discourag
latest
aha
scientif
statement
cultur
sheep
blood
agar
specimen
obtain
throat
swab
standard
laboratori
procedur
microbiolog
confirm
ga
pharyng
perform
correctli
throat
cultur
sensit
neg
result
occur
patient
receiv
antibiot
prior
sampl
sever
variabl
impact
accuraci
throat
cultur
result
one
import
manner
swab
obtain
throat
swab
specimen
obtain
surfac
tonsil
tonsillar
fossa
posterior
pharyng
wall
area
pharynx
mouth
accept
sampl
site
touch
procedur
anaerob
incub
use
select
cultur
media
report
increas
sensit
throat
cultur
howev
data
regard
impact
atmospher
incub
cultur
media
conflict
absenc
definit
benefit
increas
cost
effort
associ
anaerob
incub
select
cultur
media
difficult
justifi
durat
incub
impact
yield
throat
cultur
cultur
incub
least
hour
prior
read
addit
overnight
incub
room
temperatur
howev
identifi
substanti
posit
cultur
studi
perform
patient
pharyng
neg
radt
posit
ga
cultur
neg
hour
incub
posit
hour
therefor
although
initi
therapeut
decis
guid
neg
result
hour
advis
wait
hour
definit
result
refer
avail
onlin
wwwexpertconsultcom
patient
ga
sore
throat
estim
million
visit
primari
care
provid
adult
complain
sore
throat
year
us
antimicrobi
therapi
histor
prescrib
visit
encourag
judici
use
antibiot
trend
show
modest
declin
use
children
adolesc
diagnos
pharyng
one
studi
anoth
studi
major
asymptomat
person
posit
throat
cultur
radt
complet
cours
appropri
antimicrobi
therapi
ga
pharyng
ga
carrier
therefor
followup
test
indic
routin
followup
throat
cultur
radt
asymptomat
individu
perform
histori
rheumat
fever
consid
patient
develop
acut
pharyng
outbreak
acut
rheumat
fever
poststreptococc
acut
glomerulonephr
individu
close
semiclos
commun
outbreak
ga
pharyng
antistreptococc
antibodi
titer
valu
diagnosi
acut
ga
pharyng
use
prospect
epidemiolog
studi
differenti
true
ga
infect
ga
carriag
antistreptococc
antibodi
valuabl
confirm
prior
ga
infect
patient
suspect
acut
rheumat
fever
nonsuppur
complic
polymeras
chain
reaction
pcr
test
ga
tonsillar
tissu
shown
highli
sensit
current
avail
clinic
expens
like
restrict
use
clinic
practic
need
definit
diagnos
nonga
caus
pharyng
occur
rare
gener
ill
prolong
symptom
haemolyticum
identifi
use
standard
throat
cultur
method
intend
identifi
ga
requir
use
standard
respiratori
cultur
method
n
gonorrhoea
identifi
either
select
growth
media
use
nucleic
acid
amplif
test
ebv
routin
diagnos
use
heterophil
antibodi
monospot
low
sensit
younger
children
necessit
use
specif
antibodi
test
serum
pcr
common
virus
hsv
adenovirus
enterovirus
could
identifi
gener
viral
cultur
pcr
antimicrobi
therapi
indic
individu
symptomat
pharyng
presenc
ga
confirm
throat
cultur
radt
situat
clinic
epidemiolog
find
highli
suggest
ga
antimicrobi
therapi
initi
await
microbiolog
confirm
provid
therapi
discontinu
cultur
radt
neg
antimicrobi
therapi
ga
pharyng
shorten
clinic
cours
ill
howev
ga
pharyng
usual
self
limit
sign
symptom
resolv
spontan
within
day
onset
addit
initi
antimicrobi
therapi
delay
day
onset
ga
pharyng
still
prevent
occurr
acut
rheumat
fever
penicillin
congen
ampicillin
amoxicillin
well
numer
cephalosporin
macrolid
clindamycin
effect
treatment
ga
pharyng
sever
advisori
group
recommend
penicillin
treatment
choic
infect
ga
remain
exquisit
suscept
agent
five
decad
amoxicillin
often
use
accept
tast
suspens
efficaci
appear
equal
penicillin
oral
administ
macrolid
clarithromycin
clinic
signific
number
coloni
ga
present
inocul
agar
controversi
although
densiti
bacteria
like
greater
patient
bona
fide
acut
ga
pharyng
ga
carrier
much
overlap
coloni
count
permit
differenti
basi
degre
posit
alon
bacitracin
disk
test
wide
use
method
physician
offic
differenti
ga
streptococci
sheep
blood
agar
plate
test
provid
presumpt
identif
base
observ
ga
demonstr
zone
inhibit
around
disk
contain
unit
bacitracin
wherea
nonga
inhibit
bacitracin
altern
highli
specif
method
differenti
streptococci
perform
groupspecif
cell
wall
carbohydr
antigen
detect
test
directli
isol
bacteri
coloni
commerci
kit
avail
addit
expens
minim
improv
accuraci
may
justifi
radt
develop
identif
ga
directli
throat
swab
expens
blood
agar
cultur
offer
speed
provid
result
rapid
identif
treatment
patient
ga
pharyng
reduc
risk
spread
ga
allow
patient
return
school
work
sooner
speed
clinic
improv
addit
certain
environ
eg
emerg
depart
use
radt
compar
throat
cultur
significantli
increas
number
patient
appropri
treat
ga
pharyng
major
current
avail
radt
specif
compar
blood
agar
cultur
therapeut
decis
therefor
made
confid
basi
posit
radt
result
howev
sensit
radt
although
patient
fals
neg
radt
result
mere
ga
carrier
larg
proport
truli
infect
ga
first
radt
util
latex
agglutin
methodolog
rel
insensit
unclear
endpoint
subsequ
test
base
enzym
immunoassay
techniqu
sharpli
defin
endpoint
increas
sensit
radt
use
optic
immunoassay
oia
chemiluminesc
dna
probe
may
sensit
radt
perhap
even
sensit
blood
agar
plate
cultur
conflict
limit
data
oia
commerci
avail
radt
advisori
group
still
recommend
confirmatori
blood
agar
cultur
children
adolesc
suspect
clinic
ground
ga
pharyng
neg
radt
result
rel
sensit
differ
radt
determin
direct
comparison
studi
five
report
direct
comparison
differ
radt
hand
studi
investig
perform
radt
actual
clinic
practic
physician
investig
conclud
differ
adequaci
test
perform
one
studi
perform
three
winter
period
use
onsit
offic
test
pediatr
group
practic
radt
sensit
approxim
compar
singl
blood
agar
plate
cultur
investig
differ
pediatr
group
practic
review
experi
radt
perform
specimen
neg
radt
posit
cultur
retrospect
review
clinic
radt
perform
heterogen
inpati
outpati
group
demonstr
neg
predict
valu
npv
rang
maximum
sensit
physician
elect
use
radt
children
adolesc
without
cultur
backup
neg
result
demonstr
adequ
sampl
size
calcul
radt
sensit
throat
cultur
practic
neither
blood
agar
cultur
radt
accur
differenti
individu
ga
pharyng
carrier
howev
use
facilit
withhold
antimicrobi
therapi
great
major
macrolideresist
longitudin
investig
ga
diseas
singl
elementari
school
pittsburgh
investig
found
isol
ga
collect
resist
erythromycin
none
resist
clindamycin
molecular
type
indic
outbreak
due
singl
strain
ga
clinician
awar
local
resist
rate
current
evid
control
studi
guid
therapi
acut
pharyng
either
group
c
group
g
streptococcu
isol
one
elect
treat
regimen
similar
ga
pharyng
penicillin
antimicrobi
agent
choic
acyclovir
treatment
hsv
gingivostomat
initi
within
hour
onset
symptom
shorten
durat
ill
decreas
number
lesion
use
antivir
medic
primari
ebv
pharyng
shown
interrupt
viral
replic
temporarili
symptomat
relief
neglig
justifi
use
acyclovir
corticosteroid
recommend
ebv
pharyng
tonsillar
enlarg
threaten
airway
patenc
sever
review
larg
group
heterogen
studi
use
corticosteroid
ga
nonga
pharyng
conclud
small
measur
benefit
pain
reduct
especi
initi
earli
cours
sever
ill
advers
outcom
relat
corticosteroid
report
modest
shortliv
benefit
treatment
versu
potenti
harm
weigh
use
antimicrobi
treatment
failur
ga
pharyng
classifi
either
clinic
bacteriolog
failur
signific
erythromycin
azalid
azithromycin
also
effect
see
sulfa
drug
includ
trimethoprimsulfamethoxazol
tetracyclin
effect
use
ga
pharyng
follow
metaanalysi
clinic
trial
complet
cephalosporin
compar
penicillin
treatment
ga
tonsillopharyng
first
suggest
cephalosporin
treatment
choic
ga
tonsillopharyng
howev
sever
methodolog
flaw
notabl
inclus
ga
carrier
led
controversi
regard
conclus
indirect
evid
superior
cephalosporin
penicillin
prevent
treatment
failur
relaps
continu
appear
howev
prospect
studi
clarifi
issu
beyond
doubt
although
use
cephalosporin
ga
pharyng
could
reduc
number
person
especi
chronic
carrier
harbor
ga
complet
therapi
empir
firstlin
use
would
associ
substanti
econom
possibl
ecolog
cost
compel
reason
eg
narrow
antimicrobi
spectrum
low
cost
impress
safeti
profil
continu
use
penicillin
drug
choic
uncompl
ga
pharyng
select
use
firstgener
cephalosporin
drug
choic
may
appropri
patient
high
risk
complic
histori
rheumat
fever
sever
symptom
suspect
treatment
failur
relaps
oral
penicillin
must
administ
multipl
time
day
day
order
achiev
maxim
rate
ga
erad
attempt
treat
ga
pharyng
singl
daili
dose
penicillin
unsuccess
reduc
frequenc
dose
shorter
treatment
cours
day
may
result
better
patient
adher
therapi
sever
antimicrobi
agent
includ
clarithromycin
cefuroxim
cefixim
ceftibuten
cefdinir
cefpodoxim
effect
ga
erad
administ
day
effect
erad
oncedaili
dose
describ
amoxicillin
azithromycin
cefadroxil
cefixim
ceftibuten
cefpodoxim
cefprozil
cefdinir
howev
endpoint
studi
gener
erad
ga
symptomat
improv
prevent
rheumat
fever
two
main
clinic
reason
treatment
addit
mani
agent
broader
spectrum
activ
even
administ
short
cours
expens
standard
therapi
therefor
addit
studi
need
shortcours
dailydos
regimen
recommend
routin
tabl
give
recommend
sever
regimen
proven
efficaci
ga
pharyng
intramuscular
benzathin
penicillin
g
prefer
patient
unlik
complet
full
cours
therapi
oral
although
ga
resist
penicillin
occur
anywher
world
geograph
area
rel
high
level
resist
macrolid
antibiot
rate
ga
resist
macrolid
us
gener
remain
investig
pharyng
isol
invas
isol
ga
obtain
state
district
columbia
isol
macrolideresist
prospect
multicent
us
communitybas
surveil
studi
pharyng
ga
isol
recov
children
year
age
three
success
respiratori
season
found
macrolid
resist
clindamycin
resist
evid
increas
erythromycin
minimum
inhibitori
concentr
studi
period
howev
consider
geograph
variabl
macrolid
resist
rate
studi
year
well
yeartoyear
variabl
individu
studi
site
higher
resist
rate
report
occasion
exampl
pharyng
invas
ga
strain
collect
san
francisco
studi
difficult
problem
practic
physician
fundament
question
whether
patient
experienc
repeat
episod
ga
pharyng
ga
carrier
experienc
repeat
episod
viral
pharyng
latter
situat
far
common
patient
like
ga
carrier
clinic
epidemiolog
find
suggest
viral
etiolog
littl
clinic
respons
appropri
antimicrobi
therapi
throat
cultur
radt
posit
episod
pharyng
serolog
respons
ga
extracellular
antigen
eg
aso
antideoxyribonucleas
b
contrast
patient
repeat
episod
acut
pharyng
associ
posit
throat
cultur
radt
ga
like
experienc
repeat
episod
bona
fide
ga
pharyng
clinic
epidemiolog
find
suggest
ga
pharyng
demonstr
clinic
respons
appropri
antimicrobi
therapi
throat
cultur
radt
neg
episod
pharyng
serolog
respons
ga
extracellular
antigen
determin
patient
experienc
repeat
episod
true
ga
pharyng
physician
suggest
use
prophylact
oral
penicillin
v
howev
efficaci
regimen
proven
antimicrobi
prophylaxi
recommend
except
prevent
recurr
rheumat
fever
patient
experienc
previou
episod
rheumat
fever
tonsillectomi
may
consid
rare
patient
whose
symptomat
episod
diminish
frequenc
time
altern
explan
recurr
ga
pharyng
evid
howev
tonsillectomi
demonstr
benefici
rel
small
group
patient
benefit
rel
shortliv
complic
ga
pharyng
associ
suppur
nonsuppur
complic
see
chapter
streptococcu
pyogen
group
streptococcu
suppur
complic
result
spread
ga
adjac
structur
includ
peritonsillar
abscess
paraand
retropharyng
abscess
cervic
lymphaden
sinus
otiti
media
mastoid
antimicrobi
agent
avail
suppur
complic
ga
pharyng
common
howev
antimicrobi
therapi
greatli
reduc
frequenc
complic
clinic
treatment
failur
usual
defin
persist
recurr
sign
symptom
suggest
ga
pharyng
difficult
determin
without
repeat
isol
infect
strain
ga
ie
true
bacteriolog
treatment
failur
bacteriolog
treatment
failur
classifi
either
true
appar
true
bacteriolog
failur
refer
inabl
erad
specif
strain
ga
caus
acut
episod
pharyng
complet
cours
appropri
antimicrobi
therapi
penicillinresist
strain
ga
ever
identifi
follow
factor
suggest
establish
definit
penicillin
toler
ie
discord
concentr
penicillin
requir
inhibit
kill
organ
enhanc
colon
growth
ga
pharyng
flora
inactiv
penicillin
product
resist
intracellular
organ
antimicrobi
kill
appar
bacteriolog
failur
occur
newli
acquir
ga
isol
mistaken
origin
infect
strain
infect
strain
ga
erad
rapidli
reacquir
adher
antimicrobi
therapi
poor
howev
bacteriolog
treatment
failur
manifest
ga
carrier
state
chronic
carrier
ga
pharynx
clinic
ill
immunolog
respons
organ
colon
month
unlik
spread
ga
close
contact
low
risk
develop
suppur
nonsuppur
complic
winter
spring
temper
climat
mani
asymptomat
schoolag
children
carri
ga
ga
carrier
given
antimicrobi
therapi
primari
approach
suspect
confirm
carrier
reassur
throat
cultur
radt
perform
whenev
patient
symptom
sign
suggest
ga
pharyng
avoid
symptom
typic
viral
ill
see
clinic
episod
confirm
posit
throat
cultur
radt
treat
identif
erad
streptococc
carrier
state
desir
certain
specif
situat
antimicrobi
therapi
employ
oral
clindamycin
mgkg
per
day
mg
divid
dose
day
prefer
intramuscular
benzathin
penicillin
alon
combin
procain
penicillin
plu
oral
rifampin
mgkg
per
day
divid
dose
maximum
dose
mg
day
begin
day
penicillin
inject
also
effect
chronic
carriag
recur
upon
reexposur
ga
patient
symptom
suggest
ga
follow
treatment
throat
cultur
radt
usual
perform
posit
mani
clinician
would
elect
administ
second
cours
penicillin
therapi
patient
repeat
episod
acut
pharyng
associ
posit
throat
cultur
radt
common
